On May 28, 2019 Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), reported that it will be presenting at three upcoming conferences (Press release, Onconova, MAY 28, 2019, View Source [SID1234536608]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Acute Leukemia Forum China May 31 – Shanghai
Presentation: Fri, May 31 Steven Fruchtman, MD, President & CEO

BIO International Forum, Philadelphia June 3-6 – Philadelphia, PA
Presentation: Tues, June 4 3:15p EDT Steven Fruchtman, President & CEO
Webcast: http://www.veracast.com/webcasts/bio/internationalconvention2019/74119246905.cfm
Avi Oler, VP Corporate Development, will also attend and be available to meet with interested parties

9th Annual LD Micro Invitational June 4-5 – Bel Air, CA
Presentation: Tues, June 4 8:20a PDT Mark Guerin, CFO